On 30 May 2017
Kabra Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2017, to approve the Audited financial results with Audit Report for the year ended 31st March, 2017 & Other matters.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)